Halozyme Therapeutics, Inc. (HALO): 10-Q filed Nov 5, 2026

Form type

10-Q

Filing date

Nov 5, 2026

Accession number

0001159036-26-000145

Filer

Halozyme Therapeutics, Inc. (CIK 1159036)